Horizon PV is developing the perovskite thin film solar cell. Due to its high-performance and low-cost advantages, the perovskite solar cell has the potential to replace the Si solar cell if its stability can reach 20 years. Horizon PV intends on acting as a technology transfer company for current solar companies. Horizon PV’s vapor-assisted solution process makes their technology ideal for industrial scale manufacturing.
Graduated in 2016
Graduated in 2016
Graduate Companies
- Active Membranes
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Avesta76 Therapeutics
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete.ai
- Craytex
- CytoLumina
- DARTS Sciences
- EarlyDx
- ElectroNucleics
- EP Dynamics
- FemtoDx
- Ferrologix
- Gradient Orthodontics
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Lookin, Inc.
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- Nanoarmor, LLC.
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Nuvola Technology
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Partillion Bioscience
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- Scarless Laboratories
- SELFA
- Sixal
- Spectradyne
- Symphony Biosciences
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- ViBo Health
- Vivibaba
- Westwood Bioscience
- Zenomics
- Back to Portfolio